CNL Launches Program to Accelerate the Development of
Canada’s national nuclear laboratory expands successful Canadian Nuclear Research Initiative to include health sciences stream...
Stay updated with breaking news from Technologies Munich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canada’s national nuclear laboratory expands successful Canadian Nuclear Research Initiative to include health sciences stream...
CHALK RIVER — Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced on Oct. 18…
ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Clovis Oncology's Targeted Radionuclide Therapy candidate FAP-2286 ITM Isotope Technologies
Clovis Oncology, Inc. (NASDAQ: CLVS) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, today announced the signing of a clinical supply agreement that provides
Separate domestic and international initiatives to support the development and production of medical radioisotopes have been announced in Canada, Germany, Japan and the USA. These include a federal award of USD35 million to support the commercial production of molybdenum-99 in the USA; a new linear accelerator-based technique for production of actinium-225 in Japan; and a Canadian-German collaboration to explore the production of Ac-225.